Molecular epidemiology of carbapenem-resistant Acinetobacter baumannii isolates in Turkiye: Systematic review
- PMID: 37719251
- PMCID: PMC10500232
- DOI: 10.14744/nci.2022.17003
Molecular epidemiology of carbapenem-resistant Acinetobacter baumannii isolates in Turkiye: Systematic review
Abstract
The World Health Organization has designated carbapenem-resistant Acinetobacter baumannii (CRAB) as a "critical" pathogen on the global priority list of antibiotic-resistant bacteria. This study aims to discuss the molecular epidemiology of CRAB isolates in Turkiye in the last 12 years and the prevalence of gene regions associated with resistance or pathogenesis using a systematic review method. Our study consists of a literature search, determination of eligibility and exclusion criteria, qualitative analysis of studies, data extraction, and statistical analysis. All studies were analyzed according to the Preferred Reporting Items for Systematic Reviews and Meta-Analysis Guidelines. The incidence rates of blaOXA-23, blaOXA-23-like, blaOXA-24/40, blaOXA-24/40-like, blaOXA-51, blaOXA-51-like, blaOXA-58, and blaOXA-58-like genes in CRAB strains were 76.4%, 68.6%, 1.2%, 3.4%, 97.0%, 98.6%, 8.4%, and 17.1%, respectively. It was determined that the prevalence of the blaOXA-23 and blaOXA-58 gene regions showed a statistically significant change over the years. Due to the high prevalence of A. baumannii strains carrying the blaOXA-23 variant, it is necessary to follow its geographical distribution and transposon and plasmid movements. Based on available data, molecular surveillance of CRAB strains should be standardized. In addition, sterilization and disinfection processes applied within the scope of an effective struggle against CRAB strains that can remain live on surfaces for a long time should be reviewed frequently.
Keywords: Acinetobacter baumannii; blaoxa-23; blaoxa-24/40; blaoxa51; blaoxa58.
© Copyright 2023 by Istanbul Provincial Directorate of Health.
Conflict of interest statement
No conflict of interest was declared by the authors.
Figures
References
-
- Zarrilli R, Pournaras S, Giannouli M, Tsakris A. Global evolution of multidrug-resistant Acinetobacter baumannii clonal lineages. Int J Antimicrob Agents. 2013;41:11–9. - PubMed
-
- Maragakis LL, Perl TM. Acinetobacter baumannii epidemiology, antimicrobial resistance, and treatment options. Clin Infect Dis. 2008;46:1254–63. - PubMed
-
- Magiorakos AP, Srinivasan A, Carey RB, Carmeli Y, Falagas ME, Giske CG, et al. Multidrug-resistant, extensively drug-resistant and pandrug-resistant bacteria: an international expert proposal for interim standard definitions for acquired resistance. Clin Microbiol Infect. 2012;18:268–81. - PubMed
-
- Abozahra R, Abdelhamid SM, Elsheredy AG, Abdulwahab KE, Baraka K. Genotyping and molecular characterization of carbapenem-resistant Acinetobacter baumannii strains isolated from intensive care unit patients. Microbiol Biotechnol Lett. 2021;49:239–42.
Publication types
LinkOut - more resources
Full Text Sources